KRT8 and cancer: In the GSE6400 dataset [28], we found that KRT8 was significantly up-regulated in the A549 cell line treated with 1.25 μM and 2.5 μM of the anti-cancer agent sapphyrin PCI-2050 (p = 0.0006 and p = 0.0005, respectively) (Figure S5b).